from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3500c/yrbE4B

LFCtreatmentdescriptionclass of inhibitor

-0.457

Amikacinug/mL Amikacintranslation

-0.836

Cap5-10ug/mL Capreomycintranslation

0.052

Rox10-50 ug/mL Roxithromycintranslation

1.070

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.429

Rif0.2-5ug/mL Rifampicintranscription

-0.193

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.791

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.508

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.476

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.502

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.301

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.339

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.983

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.087

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.093

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.356

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.900

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.230

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.468

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.565

Nigericin50 uM Nigericinrespiration

0.106

TRC10-150 ug/mL Triclosanrespiration

-0.344

TRZ10-25 ug/mL Thioridazinerespiration

-1.305

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.343

menadione6-10 ug/mL Menadionerespiration

-0.223

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.746

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.135

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.141

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.630

NRP_1Non-replicating persistence stage 1dosRassociated

-0.229

Amp0.2mg/mL AmpicillincellWall

-0.268

Cephalexin20-100 ug/mL CephalexincellWall

0.418

Cerulenin0.32-5 ug/mL CerulenincellWall

0.616

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.760

EMB10-20 ug/mL EthambutolcellWall

1.165

Eta12-40 ug/mL EthionamidecellWall

0.945

INH0.2-0.4 ug/mL IsoniazidcellWall

0.280

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.373

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.695

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.372

BZA0.12 mg/mL BenzamidearomaticAmides

1.145

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.519

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.177

H2O24 mM hydrogen peroxideDNAdamaging

0.014

Levo10 ug/mL LevofloxacinDNAdamaging

0.349

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.612

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.963

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.068

UVUV-irradiationDNAdamaging

-0.737

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.614

Antimycin12.5-50 ug/mL Antimycin A?

0.053

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.279

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.031

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.567

PA8240.2-2 ug/mL PA-824?

-0.381

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.368

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.592

Verapamil50 uM Verapamil?

-0.768

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.312

methoxatin10-20 ug/mL Methoxatin?